on 19 Apr 2022
Last Applicant/ Owned by
W511, MC7100
Chicago
IL
60637
Serial Number
88983933 filed on 10th Jun 2019
Registration Number
6708009 registered on 19th Apr 2022
Correspondent Address
ALEXIS CRAWFORD DOUGLAS
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Recruitment advertisement services, namely, posting of clinical trial and health research notices for the purpose of recruiting patients for participation in clinical trials and health research; Promoting public awareness of clinical trials and scientific research; Business consulting and management in the field of clinical trials and health research, namely, management and compilation of computer Read More
Recruitment advertisement services, namely, posting of clinical trial and health research notices for the purpose of recruiting patients for participation in clinical trials and health research; Promoting public awareness of clinical trials and scientific research; Business consulting and management in the field of clinical trials and health research, namely, management and compilation of computerized databases in the field of clinical trials and health research for business purposes
28th May 2020
28th May 2020
Medical and scientific research, namely, conducting clinical trials and health research for others; Providing medical and scientific research information in the field of clinical trials; Providing an Internet website portal in the field of clinical trials and scientific research
28th May 2020
28th May 2020
No 88983933
No Service Mark
No 3724954-004
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
19th Apr 2022 | REGISTERED-PRINCIPAL REGISTER |
16th Mar 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
15th Mar 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
09th Mar 2022 | STATEMENT OF USE PROCESSING COMPLETE |
09th Mar 2022 | DIVISIONAL PROCESSING COMPLETE |
04th Mar 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
23rd Feb 2022 | USE AMENDMENT FILED |
23rd Feb 2022 | TEAS REQUEST TO DIVIDE RECEIVED |
23rd Feb 2022 | TEAS STATEMENT OF USE RECEIVED |
22nd Feb 2022 | DIVISIONAL REQUEST RECEIVED |